Full Press Release Details
Healthcare Technologies Inc. Sets
Year 2021 Earnings Call for
December 22, 2022, at 4:00 p.m. ET
York/December 21, 2022 - MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the
"Company"), announced today that the Company will hold a conference call on Thursday, December 22, 2022, at 4:00 p.m. Eastern
Time (1:00 p.m. Pacific Time) to discuss its financial results for the full year ended December 31, 2021. Financial results and audited
financial statements for the fiscal year ended December 31, 2021 have been issued pursuant to the Company's Annual Report on Form
20-F filed with the U.S. Securities and Exchange Commission on November 14, 2022.
the call, the Company's management will host a presentation, followed by a question-and-answer period.
Thursday, December 22, 2022
4:00 p.m. Eastern Time (1:00 p.m. Pacific Time)
U.S. dial-in number: +1-877-270-2148
number: +1-412-902-6510
toll free: 0066-33-1-33094
conference call will broadcast live at https://event.choruscall.com/mediaframe/webcast.html?webcastid=BASgJkn3 and will be available
for replay at: https://services.choruscall.com/ccforms/replay.html.
call the conference telephone number 10 minutes before the start time. An operator will register your name and organization. If you have
any difficulty connecting with the conference call, please contact the Company investor relations team at ir@medirom.co.jp.
replay of the call will be available after 6:00 p.m. Eastern Time on the same day through January 5, 2023 at 11:59 PM Eastern Time.
replay number: +1-877-344-7529
replay number: +1-412-317-0088
MEDIROM Healthcare Technologies Inc.
a holistic healthcare company, operates 312 (as of November 30, 2022) relaxation salons across Japan, Re.Ra.Ku , being
its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business, and launched new healthcare programs
using on-demand training app called "Lav ", which is developed by the Company. MEDIROM also entered the device
business in 2020 and has developed a smart tracker "MOTHER Bracelet ". MEDIROM hopes that its diverse health
related services and products offering will help it collect and manage healthcare data from users and customers and enable it to become
a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en
statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities
Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company's possible or
assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry
environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may,"
"will," "should," "design," "target," "aim," "hope," "expect,"
"could," "intend," "plan," "anticipate," "estimate," "believe,"
"continue," "predict," "project," "potential," "goal," or other words that
convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company's future financial
performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results,
levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance
or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements
since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control
and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking
statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties
and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. The Company assumes
no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could
differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.